GALT - 1.81 Pre-market now at 2.00/2.01 GR-MD-02 Demonstrates Clinically Significant Effect in Patients with Severe and Refractory Atopic Dermatitis (Eczema) http://stockcharts.com/c-sc/sc?s=GALT&p=D&b=5&g=0&i=t19099576142&r=1489496656763 http://stockcharts.com/c-sc/sc?s=GALT&p=W&b=5&g=0&i=t02514734644&r=1489496674941